References

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2021 · External reference

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

2018 · External reference

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer

2013 · External reference

10.1016/j.phrs.2017.07.013

10.1016/j.phrs.2017.07.013 · External reference

Repurposing of approved cardiovascular drugs

2016 · External reference

10.1016/j.canlet.2018.01.058

10.1016/j.canlet.2018.01.058 · External reference

The Clinical Relevance of Cancer Cell Lines. JNCI

10.1093/jnci/djt007 · 2013 · External reference

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations

10.1002/ijc.21570 · 2006 · External reference

The NCI60 human tumour cell line anticancer drug screen

10.1038/nrc1951 · 2006 · External reference

Unresolved reference

External reference

An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules

10.1016/j.cell.2013.08.003 · 2013 · External reference

10.1093/nar/gks1111

10.1093/nar/gks1111 · External reference

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat

2020 · External reference

A Landscape of Pharmacogenomic Interactions in Cancer

2016 · External reference

Correlating chemical sensitivity and basal gene expression reveals mechanism of action

2016 · External reference

Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells

2017 · External reference

Guidelines for the selection of functional assays to evaluate the hallmarks of cancer. Biochim Biophys Acta BBA – Rev

2016 · External reference

ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients

2019 · External reference

10.1093/nar/gkx1037

10.1093/nar/gkx1037 · External reference

Overcoming cancer therapeutic bottleneck by drug repurposing

2020 · External reference

10.3332/ecancer.2018.886

10.3332/ecancer.2018.886 · External reference

Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients

2020 · External reference

10.1093/carcin/bgab024

10.1093/carcin/bgab024 · External reference

First Global Approval

2013 · External reference

10.1056/nejmoa064320

10.1056/nejmoa064320 · External reference

10.1016/j.phrs.2018.11.014

10.1016/j.phrs.2018.11.014 · External reference

10.1016/j.ijbiomac.2020.12.009

10.1016/j.ijbiomac.2020.12.009 · External reference

Molecular cloning and characterization of a novel cbl-family gene, cbl-c

1999 · External reference

Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma

10.1038/s41388-022-02180-6 · 2022 · External reference

Collections of Simultaneously Altered Genes as Biomarkers of Cancer Cell Drug Response

10.1158/0008-5472.can-12-3122 · 2013 · External reference

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

10.2147/bctt.s115600 · 2017 · External reference

An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

10.1158/1078-0432.ccr-12-1558 · 2013 · External reference

10.1093/database/bay041

10.1093/database/bay041 · External reference

10.1093/nar/gkaa968

10.1093/nar/gkaa968 · External reference